New BPA call entitled, "external peer review of research and materials related to the FDA consumer research on the healthy symbol".
Ended Awarded Last action
- Contract number
- 75F40121F19016
- Awardee
-
Versar, Inc. UEI KTERFRZBVP66
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $36,097
Award facts
- Contract value 100% obligated
- $36,097.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541620 Environmental Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Berwyn Heights, MD 20740, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $36,097 |
About this award
The Food and Drug Administration awarded a Blanket Purchase Agreement (BPA) call to Versar, Inc. valued at $36,097.13 for external peer review services related to FDA consumer research on the Healthy Symbol. The contract, awarded on June 29, 2021, is a firm fixed-price engagement performed in Berwyn Heights, Maryland. This BPA call represents a focused scope of work under Versar's broader GSA Professional Services Schedule contract, enabling the contractor to provide specialized scientific peer review and evaluation services to support FDA initiatives.
The award included a no-cost extension extending performance through September 30, 2023, beyond the original completion date of May 31, 2023. Versar, Inc., a Washington, D.C.-based professional services firm with extensive experience in technical and scientific consulting, was selected without a set-aside designation, competing in open competition. The contractor's expertise in peer review services, demonstrated through similar work on EPA contracts and other federal engagements, positions it well to deliver the external evaluation and analysis of research materials supporting FDA's consumer research objectives on health-related labeling symbols.
Quick answers
Who was awarded contract 75F40121F19016?
75F40121F19016 was awarded to Versar, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 29, 2021.
How much is contract 75F40121F19016 worth?
The government has obligated $36,097 on 75F40121F19016.
Is contract 75F40121F19016 an order under another contract?
Yes. 75F40121F19016 is a BPA call under GS00F0007L-HHSF223201700015B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40121F19016 competed?
The extent of competition for 75F40121F19016 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award